Page last updated: 2024-12-06

myrtenal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Myrtenal is a monoterpene aldehyde with a characteristic pine-like odor. It is found naturally in various essential oils, including those from pine needles, eucalyptus, and myrtle. It is synthesized through the oxidation of alpha-pinene, a common constituent of pine trees. Myrtenal is known for its antimicrobial and antifungal properties. It has been investigated for potential use in treating infections and as a preservative in food and cosmetic products. Additionally, myrtenal has shown potential as an anti-inflammatory agent and has been studied for its effects on the nervous system. Its aroma is also valued in the fragrance industry.'

myrtenal: RN refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID61130
SCHEMBL ID228374
MeSH IDM0170634

Synonyms (32)

Synonym
bicyclo[3.1.1]hept-2-ene-2-carboxaldehyde, 6,6-dimethyl-
bicyclo[3.1.1]hept-2-ene-2-carboxaldehyde,6-dimethyl-
564-94-3
nsc54384
2-norpinene-2-carboxaldehyde,6-dimethyl-
(1s,5r)-(+)-6,6-dimethyl-2-norpinene-2-carboxaldehyde
d-myrtenal
(+)-myrtenal
(1s)-myrtenal
(1s,5r)-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxaldehyde
(1s)-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxaldehyde
bicyclo(3.1.1)hept-2-ene-2-carboxaldehyde, 6,6-dimethyl-
myrtenal
LMPR0102120023
2-norpinene-2-carboxaldehyde, 6,6-dimethyl- (8ci)
(1r)-2-pinen-10-al
BMSE000534
(1r)-(-)-myrtenal
AKOS000120250
SCHEMBL228374
(1r)-(-) myrtenal
6,6-dimethyl-bicyclo [3.1.1]hept-2-ene-2-carbaldehyde
6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde
6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde #
bicyclo[3.1.1]hept-2-ene-2-carboxaldehyde,6,6-dimethyl-
fema 3395
6,6-dimethyl-bicyclo[3,1,1]hept-2-ene-2-carboxaldehyde
J-011849
DTXSID60865112
CS-0081952
EN300-20224
SY107034

Research Excerpts

Overview

Myrtenal is a novel class of compound belongs to monoterpenes found predominantly in mint, pepper, etc. It has excellent pharmacological activities against many diseases among which cancer is imperative.

ExcerptReferenceRelevance
"Myrtenal is a novel class of compound belongs to monoterpenes found predominantly in mint, pepper, etc., and it was shown to have excellent pharmacological activities against many diseases among which cancer is imperative. "( Myrtenal ameliorates diethylnitrosamine-induced hepatocarcinogenesis through the activation of tumor suppressor protein p53 and regulation of lysosomal and mitochondrial enzymes.
Lingaiah, HB; Natarajan, N; Periyasamy, BM; Srinivasan, P; Thamaraiselvan, R, 2013
)
3.28

Treatment

The Myrtenal-treated groups exhibited a decreased TC, TG, and LDLc levels. Treatment with myrtenal significantly (p < 0.05) improved the levels of plasma glucose, pancreatic insulin and lipid profiles.

ExcerptReferenceRelevance
"The Myrtenal-treated groups exhibited a decreased TC, TG, and LDLc levels; increased HDLc levels; and a decline in the inflammatory cytokines such as CRP, IL-1β, IL-8, and IL-18 when compared to the untreated AS rats."( Anti-atherosclerotic Effects of Myrtenal in High-Fat Diet-Induced Atherosclerosis in Rats.
Gao, X; Liu, H; Ma, X; Seshadri, VD; Yu, L, 2022
)
1.49
"Myrtenal treatment caused improvement in urinary bladder mucosa with cells more likely in Grade 1."( Chemopreventive Potential of Myrtenal against Nitrosamine-Initiated, Radiation-Promoted Rat Bladder Carcinogenesis.
Ahmed, EK; Ezz, MK; Farrag, MA; Ibrahim, NK, 2022
)
1.73
"Treatment with myrtenal significantly (p < 0.05) improved the levels of plasma glucose, pancreatic insulin and lipid profiles."( Myrtenal alleviates hyperglycaemia, hyperlipidaemia and improves pancreatic insulin level in STZ-induced diabetic rats.
Ayyasamy, R; Leelavinothan, P, 2016
)
2.22
"Treatment with myrtenal to cancer bearing animals resulted in remarkable increase in the inherent antioxidants and excellent modulation in the proteins of apoptotic and anti-apoptotic cascade."( Myrtenal attenuates diethylnitrosamine-induced hepatocellular carcinoma in rats by stabilizing intrinsic antioxidants and modulating apoptotic and anti-apoptotic cascades.
Balasubramanian, MP; Hari Babu, L; Perumal, S, 2012
)
2.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.33)18.7374
1990's0 (0.00)18.2507
2000's4 (13.33)29.6817
2010's17 (56.67)24.3611
2020's8 (26.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.95 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]